GENE ONLINE|News &
Opinion
Blog

2025-05-05|

Venture Capital Firm to Invest in Therapeutics, Medical Devices, and Healthcare Services Following New Funding Round

by Mark Chiang
Share To

NEWSFLASH

A venture capital firm plans to invest in companies focused on therapeutics, medical devices, and healthcare services after securing new funding. The firm is known for its frequent investments in early-stage drug companies. The firm intends to use the capital to support companies developing new treatments, medical technologies, and healthcare delivery models. This investment strategy aligns with the firm’s established focus on backing innovative startups within the healthcare sector.

Newsflash | Powered by GeneOnline AI
Date: May 5, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
A Look at Taiwan-German Collaborative Solutions in Precision Medicine, Drug Development, and Medical Tech
2025-05-21
LATEST
A Look at Taiwan-German Collaborative Solutions in Precision Medicine, Drug Development, and Medical Tech
2025-05-21
ACOG Updates Pain Management Guidelines for IUD Insertions as Novavax Vaccine Gains Approval
2025-05-20
NIH Restores Research Funding to Previously Defunded Scientists Amid Policy Shifts
2025-05-20
Prime Medicine Reduces Workforce by 25 Percent and Appoints David Schenkein as New CEO
2025-05-20
UnitedHealth Group Stock Drops Amid Rising Medicare Advantage Costs and Regulatory Debates
2025-05-20
Trump Science Adviser Michael Kratsios Calls for Renewed Focus on Reproducible Research Practices to Address Scientific Stagnation
2025-05-20
House Republicans Propose $700 Billion Medicaid Savings with Work Requirements
2025-05-20
EVENT
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
2025-06-16
US BIO International Convention
Boston, U.S.A.
Scroll to Top